Poruk et al. [92] concluded that epithelial markers, such as cytokeratin, and cancer stem-cell markers, ALDH, CD133, CD44, on the surface of CTCs in the blood were independently predictive of poor survival and cancer recurrence. This evidence concerns the gene PROM1 and cancer.